Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Co.'s pipeline includes product candidates that utilize its understanding of the tumor microenvironment, including both angiogenesis-targeted agents and immune-oncology focused agents. These product candidates are designed to support critical components required for an anti-tumor response to cancer. These include modulation of the microvasculature via angiogenesis-targeted agents, and induction of an immune response via activators on effector cells in the tumor microenvironment. We show 9 historical shares outstanding datapoints in our CMPX shares outstanding history coverage, used to compute CMPX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CMPX market cap history over the course of time is important for investors
interested in comparing CMPX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CMPX versus a peer is one thing; comparing
CMPX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CMPX can fluctuate over the course of history.
With this page we aim to empower investors researching CMPX by allowing them to research the CMPX market cap history. |
Free CMPX Email Alerts:
Video: The Importance of Market Cap
